S 2535 (see companion bill H 7706) – Rhode IslandStatus: Inactive / Dead
Year Introduced: 2018
THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT: Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.